PVSS10. National Outcomes and Charges for Claudication and Limbthreat: Angioplasty Versus Bypass Graft  by Sachs, Teviah et al.
JOURNAL OF VASCULAR SURGERY
June Supplement 201052S AbstractsV. S. Kashyap: Nothing to disclose; T. P. Sarac: Noth-
ing to disclose.
PVSS10.
National Outcomes and Charges for Claudication and
Limbthreat: Angioplasty Versus Bypass Graft
Teviah Sachs, Frank Pomposelli, Mark Wyers, Allen Ham-
dan, Marc L. Schermerhorn. Beth Israel Deaconess Medi-
cal Center, Boston, MA
Objectives: Assess Outcomes & Costs in Patients with
Lower Extremity Vascular Disease Undergoing Intervention.
Methods: We used the NIS database (1998-07), se-
lecting those with atherosclerosis & intervention for clau-
dication (CL) [ICD-9: 440.21] or limbthreat (LT)
[440.22-24] with angioplasty / stent (PTA) [39.50,
39.90], aorto-femoral bypass (AFB) [39.25], & peripheral
bypass (BPG) [39.29]. We evaluated demographics, co-
morbidities, charges & adjusted mortality & major ampu-
tation.
Results: There were 563, 142 patients: PTA: 218, 656
(38%), BPG: 280, 022 (50%), AFB: 36, 307 (6%). PTA
patients were older than BPG (71 v 70y), more often
female (46 v 42%), had similar but lower mortality than
BPG for CL (.2 v .4%) and LT (2.1 v 2.5%). PTA had higher
major amputation for LT (7% v 4%) [all p 0.01]. Median
LOSwas lowest for PTA (CL:1d, LT:3d), followed by BPG
(CL:3d, LT:6d) and AFB (CL:5d, LT:7d) [all p  0.01].
Total procedures for CL rose 58% (24, 488 - 38, 785),
while charges rose 228% ($0.46 - $1.5 billion). Procedures
for LT rose 5% (34, 402 - 36, 147) while charges rose 112%
($1.1 to $2.3 billion) [Figure]. For CL and LT, PTA has
surpassed BPG & AFB combined.
Conclusions: PTA has altered the treatment paradigm
for lower limb ischemia with increased procedures &
charges. It is unclear if this represents an increase in patients
or number of treatments per patient. Although mortality is
lower with PTA, limb loss appears higher, necessitating
longitudinal studies to determine the appropriateness of
PTA for these patients. Themortality benefit with PTAmay
be ultimately lost if multiple interventions are performed
on the same patients.
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Management of Dialysis-Dependent Patients With
Critical Limb Ischemia
Jonathan Kittredge3, Purandath Lall2, Linda M. Harris3,
Maciej L. Dryjski3, Hasan H. Dosluoglu1. 1SUNY at Buf-
falo, VAWestern NYHealthcare System, Buffalo, NY; 2VA
Western NY Healthcare System, Buffalo, NY; 3SUNY at
Buffalo, Buffalo, NY
Objectives: The goal of our study was to assess the
current management strategies in dialysis-dependent pa-
tients with critical limb ischemia (CLI), and to identify
parameters associated with limb loss in this patient popula-
tion.
Methods: Dialysis-dependent patients who presented
with CLI (Rutherford 4-6) between 06/2001-06/2009
were retrospectively analyzed.
Results: There were 94 patients (82% males, 119
limbs, mean age 67  10). Co-morbidities included CAD
(87%), hypertension (86%), DM (78%), non-ambulatory
status (26%). Indications were rest pain (18%), non-healing
ulcer (23%), gangrene (53%), and advanced foot sepsis
(7%). Primary amputation (PA) was performed in 20%; 26%
underwent open bypass, 54% had endovascular (EV) inter-
ventions. More EV-treated patients had gangrene than
open group (63% vs 39%, p  0.047). The most distal
intervention was infrapopliteal in 47% of patients (open,
51%; endovascular, 62%, p 0.259). Two-year survival was
worse in PA group (21 8%, vs 51 9% in open, 41 7%
in EV, p  0.088). Limb salvage (LS) was similar in open
and EV groups (2-year LS 60  9.7% vs 58  8%, p 
0.690). Amputation-free survival (AFS) was also similar
(2-year AFS 38 9% in open vs 28 6% in EV, p 0.304).
Multivariate analysis showed only non-ambulatory status
(OR: 3.0, 95% CI, 1.4-6.8, p  0.007) and gangrene
(OR:2.7, 1.1-6.5, p  0.027) being independently associ-
ated with limb loss after limb salvage attempt. The LS rate
was 0% at 6 months in non-ambulatory patients with gan-
grene (n  15), whereas it was 70  8% in ambulatory
patients with gangrene (n  37). Only 6 of the 15 non-
ambulatory patients with gangrene who had LS attempt did
not have an amputation; all died within 3 months with
non-healed wounds.
Conclusions:EV interventions play a significant role in
the current management of dialysis-dependent patients
with CLI, with similar results to open reconstructions.
Non-ambulatory dialysis patients with gangrene carry a
dismal prognosis and primary amputation should be con-
sidered as the initial modality.
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